Bitcoin has closed 28 consecutive daily sessions within the body of a single candlestick, a rare pattern noted by analyst SuperBitcoinBro. Historically, this pattern has appeared five times, with subsequent price moves continuing in the direction of the initial breakout. Currently, there is no confirmed breakout, and the next move depends on whether buyers can defend the lower range boundary. This pattern highlights a period of price consolidation that could precede a significant directional move once the range is broken.
Bitcoin's rare 28-day closing pattern is noted alongside a broad crypto market rally where 44 of 50 major cryptocurrencies on Pluang rose. For readers following the crypto sector, here is Pluang's market snapshot as of Oct 21, 2026 01:21 WIB: BAT (Basic Attention Token) gained 11.27% with 84% sell orders, BAL (Balancer) rose 11.14%, and THETA (Theta Network) increased 8.89% despite 100% sell order activity. This data reflects diverse trading behaviors and price movements across key digital assets.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
